Jennifer is a leader in the Next Generation Therapies practice at Deloitte. She has a deep understanding of the CGT value chain and manufacturing processes from procurement to delivery across global markets. She leads the Global Deloitte Next Gen Therapies Industry Working Group which brings together cell & gene therapy executives and key opinion leaders to share leading practices, harmonize industry standards and develop solutions focused on transformative improvements for patients, providers and relevant stakeholders.